Access Accelerated Brings Together Leaders to Discuss NCD Solutions During UNGA Week

To a standing-room only audience atop McCann Worldgroup headquarters in New York City, Access Accelerated hosted a special UN General Assembly side event with multisector leaders working to tackle non-communicable diseases around the world. The event began with an interactive marketplace where nine Access Accelerated member companies–Astellas, Bristol-Myers Squibb, Eisai, Merck KGaA, Pfizer, Roche, Sanofi, Shionogi and Daiichi-Sankyo–showcased NCD access programs that address the deadliest NCDs like cancer, diabetes and heart disease.

Read More

Access Accelerated at the 72nd Session of the UN General Assembly

During the United Nations General Assembly week, join Access Accelerated for an exclusive, thought-provoking forum addressing the growing burden of non-communicable diseases (NCDs) in Africa, Latin America and Asia. The event will feature an in-depth panel discussion with global leaders from public health, government and the biopharmaceutical industries on how the public and private sectors can come together to develop solutions that drive progress toward meeting the UN Sustainable Development Goal to reduce premature deaths from NCDs by one-third by 2030. 

Guests will also have the opportunity to explore a marketplace of exhibits from current partner initiatives around the world, and meet other leaders in global health during a networking reception.

Read More